Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults — VISION Network, 10 States, December 2021–March 2022
暂无分享,去创建一个
William F. Fadel | C. Mcevoy | M. Stockwell | R. Link-Gelles | S. Schrag | P. Embí | K. Natarajan | S. Grannis | E. Azziz-Baumgartner | B. Fireman | A. Naleway | Sarah Ball | M. Gaglani | M. Thompson | J. Verani | Toan C Ong | Patrick K. Mitchell | B. Dixon | M. Mamawala | Jonathan M. Davis | N. Klein | Stephanie A. Irving | M. DeSilva | N. Lewis | J. Ferdinands | Sue B. Reynolds | E. Stenehjem | Mehiret H. Wondimu | Eric P. Griggs | K. Goddard | O. Zerbo | Alexandra F Dalton | Gabriela Vazquez Benitez | A. Kharbanda | M. Dunne | W. Fadel | K. Dascomb | Catherine H Bozio | M. Barron | N. Prasad | Jungmi Han | Chandni Raiyani | Kristin Goddard | Jeremiah Williams | E. Griggs | Monica Dickerson | S. Rao | P. Patel | N. Grisel | Duck-Hye Yang | Julie Arndorfer | S. Irving | Michael E. Smith | S. Reynolds | J. Arndorfer | C. Raiyani | E. Rowley | N. Valvi | S. Ball | M. Dickerson | Elizabeth A. K. Rowley | Sarah W. Ball | Ousseny Zerbo | Nimish Valvi | E. Azziz‐Baumgartner